Lundbeck
HLUN-B.CO
#2602
Rank
NZ$12.17 B
Marketcap
NZ$12.27
Share price
-0.35%
Change (1 day)
-0.16%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2026 (TTM): NZ$1.31

According to Lundbeck's latest financial reports the company's current EPS (TTM) is NZ$1.36. In 2025 the company made an earnings per share (EPS) of NZ$0.90 an increase over its 2024 EPS that were of NZ$0.79.

EPS history for Lundbeck from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$1.3145.05%
2025NZ$0.9014.5%
2024NZ$0.7929.29%
2023NZ$0.6123.09%
2022NZ$0.5037.26%
2021NZ$0.36-84.61%
2020NZ$2.34-24.61%
2019NZ$3.11-42.06%
2018NZ$5.3740.7%
2017NZ$3.81146.26%
2016NZ$1.55-120.48%
2015NZ-$7.563231.32%
2014NZ-$0.23-115.78%
2013NZ$1.44-23.36%
2012NZ$1.88-48.01%
2011NZ$3.61-9.68%
2010NZ$4.0013.72%
2009NZ$3.5124.32%
2008NZ$2.83-6.05%
2007NZ$3.0181.77%
2006NZ$1.66-16.76%
2005NZ$1.99-17.58%
2004NZ$2.41